Towarzystwo Funduszy Inwestycyjnych Pzu Sa Regenxbio Inc. Transaction History

Towarzystwo Funduszy Inwestycyjnych Pzu Sa

  • $422 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Aug 14, 2025
SELL
$29.09 - $45.68 $113,451 - $178,152
-3,900 Closed
0 $0
Q1 2021

Aug 14, 2025
BUY
$33.61 - $49.95 $131,079 - $194,805
3,900 New
3,900 $133 Million

Others Institutions Holding RGNX

# of Institutions
189
Shares Held
44.3M
Call Options Held
138K
Put Options Held
117K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $498M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Towarzystwo Funduszy Inwestycyjnych Pzu Sa Portfolio

Follow Towarzystwo Funduszy Inwestycyjnych Pzu Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Towarzystwo Funduszy Inwestycyjnych Pzu Sa, based on Form 13F filings with the SEC.

News

Stay updated on Towarzystwo Funduszy Inwestycyjnych Pzu Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email